Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Buclin

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|March 18, 2008
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipientsN Perrottet, C Robatel, P Meylan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 15, 2024
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An updateM Briki, A Murisier, M Guidi, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Population pharmacokinetics of imatinib and the role of alpha-acid glycoproteinN Widmer, L A Decosterd, C Csajka, et al.
Annales Pharmaceutiques Francaises|May 20, 2006
[Effects of oral cannabis and dronabinol on driving capacity]C Giroud, M Augsburger, B Favrat, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 1, 2009
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirineA Fayet, A Béguin, B Zanolari, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirN Perrottet, C Csajka, M Pascual, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individualsM Arab-Alameddine, J Di Iulio, T Buclin, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Scientific Reports|June 4, 2024
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I studyR Audran, H Chtioui, A C Thierry, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 17, 2013
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applicationsU Winterfeld, A Allignol, A Panchaud, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|March 18, 2008
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipientsN Perrottet, C Robatel, P Meylan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 15, 2024
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An updateM Briki, A Murisier, M Guidi, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Population pharmacokinetics of imatinib and the role of alpha-acid glycoproteinN Widmer, L A Decosterd, C Csajka, et al.
Annales Pharmaceutiques Francaises|May 20, 2006
[Effects of oral cannabis and dronabinol on driving capacity]C Giroud, M Augsburger, B Favrat, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 1, 2009
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirineA Fayet, A Béguin, B Zanolari, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirN Perrottet, C Csajka, M Pascual, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individualsM Arab-Alameddine, J Di Iulio, T Buclin, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Scientific Reports|June 4, 2024
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I studyR Audran, H Chtioui, A C Thierry, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 17, 2013
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applicationsU Winterfeld, A Allignol, A Panchaud, et al.
Pageof 11